Stanford University researchers have discovered why some people with attention deficit hyperactivity disorder may do well on ...

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

Labels of all extended-release stimulants indicated for ADHD -- including certain formulations of amphetamine and ...

Medically reviewed by Paria Sanaty Zadeh, PharmD Attention-deficit/hyperactivity disorder (ADHD) medications can be ...

Methylphenidate (Ritalin, MPH) is a psychostimulant drug approved for treatment of attention-deficit hyperactivity disorder, postural orthostatic tachycardia syndrome and narcolepsy.It may also be ...

The combined use of selective serotonin reuptake inhibitors and methylphenidate did not significantly increase adverse event risk among adults with ADHD and comorbid depression, according to a ...

Methylphenidate has a possibility to interact with more drugs. These interactions are harmful. Drug interactions can be prevented by avoiding unwanted drug combinations.

Ritalin is the latest attention deficit hyperactivity disorder (ADHD) medication in short supply—after a months-long Adderall shortage—leaving patients who rely on these drugs to manage daily ...

This has been methylphenidate versus placebo for treating fatigue in people with advanced cancer, randomized, double-blind, multicenter, placebo-controlled clinical trial. And again, this is a dual ...

D’Aiello B, Gessi L, Menghini D, Vicari S, De Rossi P. Sleep disturbances in children with ADHD on methylphenidate monotherapy: the role of dysregulation profile. Sleep Med . 2025:128:153-158 ...

A shortage affecting Adderall has now led to intermittent supply of other ADHD drugs, including the commonly prescribed methylphenidate, often known by brand names Ritalin or Concerta.